These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16609062)

  • 1. Molecular targets in melanoma from angiogenesis to apoptosis.
    Sosman JA; Puzanov I
    Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2376s-2383s. PubMed ID: 16609062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma.
    Panka DJ; Atkins MB; Mier JW
    Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2371s-2375s. PubMed ID: 16609061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches.
    Eberle J; Kurbanov BM; Hossini AM; Trefzer U; Fecker LF
    Drug Resist Updat; 2007 Dec; 10(6):218-34. PubMed ID: 18054518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development.
    Tran MA; Smith CD; Kester M; Robertson GP
    Clin Cancer Res; 2008 Jun; 14(11):3571-81. PubMed ID: 18519791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy and targeted therapy combinations in advanced melanoma.
    Flaherty KT
    Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2366s-2370s. PubMed ID: 16609060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor angiogenesis in melanoma.
    Marneros AG
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):431-46, vii-viii. PubMed ID: 19464595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapy for uveal melanoma.
    Triozzi PL; Eng C; Singh AD
    Cancer Treat Rev; 2008 May; 34(3):247-58. PubMed ID: 18226859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities and obstacles to combination targeted therapy in renal cell cancer.
    Sosman JA; Puzanov I; Atkins MB
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):764s-769s. PubMed ID: 17255307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-molecule and antibody approaches to molecular chemotherapy of primary brain tumors.
    Newton HB
    Curr Opin Investig Drugs; 2007 Dec; 8(12):1009-21. PubMed ID: 18058572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells.
    Marín YE; Wall BA; Wang S; Namkoong J; Martino JJ; Suh J; Lee HJ; Rabson AB; Yang CS; Chen S; Ryu JH
    Melanoma Res; 2007 Oct; 17(5):274-83. PubMed ID: 17885582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecularly targeted therapy for melanoma: current reality and future options.
    Becker JC; Kirkwood JM; Agarwala SS; Dummer R; Schrama D; Hauschild A
    Cancer; 2006 Nov; 107(10):2317-27. PubMed ID: 17039502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies.
    Basu B; Biswas S; Wrigley J; Sirohi B; Corrie P
    Expert Rev Anticancer Ther; 2009 Nov; 9(11):1583-98. PubMed ID: 19895243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma.
    Wang Z; Zhou J; Fan J; Qiu SJ; Yu Y; Huang XW; Tang ZY
    Clin Cancer Res; 2008 Aug; 14(16):5124-30. PubMed ID: 18698030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects for non-immunological molecular therapeutics in melanoma.
    Eustace AJ; Mahgoub T; Tryfonopoulos D; O'Donovan N; Crown J
    J BUON; 2010; 15(1):9-18. PubMed ID: 20414921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.
    Gollob JA; Wilhelm S; Carter C; Kelley SL
    Semin Oncol; 2006 Aug; 33(4):392-406. PubMed ID: 16890795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selected combination therapy with sorafenib: a review of clinical data and perspectives in advanced solid tumors.
    Dal Lago L; D'Hondt V; Awada A
    Oncologist; 2008 Aug; 13(8):845-58. PubMed ID: 18695262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current strategies in overcoming resistance of cancer cells to apoptosis melanoma as a model.
    Hersey P; Zhuang L; Zhang XD
    Int Rev Cytol; 2006; 251():131-58. PubMed ID: 16939779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic therapy for metastatic malignant melanoma--from deeply disappointing to bright future?
    Lorigan P; Eisen T; Hauschild A
    Exp Dermatol; 2008 May; 17(5):383-94. PubMed ID: 18312390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approaches in metastatic melanoma: biological and molecular targeted therapies.
    Lejeune FJ; Rimoldi D; Speiser D
    Expert Rev Anticancer Ther; 2007 May; 7(5):701-13. PubMed ID: 17492933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma treatment update.
    Tsao H; Sober AJ
    Dermatol Clin; 2005 Apr; 23(2):323-33. PubMed ID: 15837158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.